Pulmonary Surfactant and Respiratory Diseases |

Description

Composition and structural characteristics of the pulmonary surfactant seeking its greatest therapeutic efficacy.
Functional tests with a captive bubble surfactometer.
Analysis of the lipid composition of the surfactants.
Dynamics, understanding-expansion and stability of the surfactants.
Pathogenesis of the inactivation of the surfactant in acute lung damage.
Screening tests for surfactant replacement in preterm infants.
Nanotoxicity: the study of the impact of certain drugs, liposomes and nanoparticles on the structure and function of the pulmonary surfactant.
Nanopharmacology: the study of the pulmonary surfactant as a route for drug administration. Surfactant-promoted diffusion of the pharmaceuticals towards the alveoli.
Biophysical models used to optimize interface vehiculation.